References
Ungprasert P, Koster MJ, Thongprayoon C, Warrington KJ (2016) Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis. Clin Rheum. doi:10.1007/s10067-016-3394-7
Zoller B, Li X, Sundquist J, Sundquist K (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 379(9812):244–249. doi:10.1016/S0140-6736(11)61306-8
Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC Jr et al (2005) Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener’s clinical occurrence of thrombosis (WeCLOT) study. Ann Intern Med 142(8):620–626
Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L, French Vasculitis Study Group (2009) High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis 68(4):564–567. doi:10.1136/ard.2008.099051
van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA et al (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1(8426):425–429
Novikov P, Makarov E, Moiseev S, Meshkov A, Strizhakov L (2015) Venous thromboembolic events in systemic vasculitis. Ann Rheum Dis 74(3):e27. doi:10.1136/annrheumdis-2014-206849
Faurschou M, Obel N, Baslund B (2014) High risk of pulmonary embolism and deep venous thrombosis but not of stroke in granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res 66(12):1910–1914. doi:10.1002/acr.22423
Stassen PM, Derks RP, Kallenberg CG, Stegeman CA (2008) Venous thromboembolism in ANCA-associated vasculitis—incidence and risk factors. Rheumatology 47(4):530–534. doi:10.1093/rheumatology/ken035
Salmela A, Ekstrand A, Joutsi-Korhonen L, Raisanen-Sokolowski A, Lassila R (2015) Activation of endothelium, coagulation and fibrinolysis is enhanced and associates with renal anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i53–i59. doi:10.1093/ndt/gfu379
Kambas K, Chrysanthopoulou A, Vassilopoulos D, Apostolidou E, Skendros P, Girod A et al (2014) Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis 73(10):1854–1863. doi:10.1136/annrheumdis-2013-203430
Horvei LD, Grimnes G, Hindberg K, Mathiesen EB, Njolstad I, Wilsgaard T et al (2016) C-reactive protein, obesity, and the risk of arterial and venous thrombosis. J Thromb Haemost 14(8):1561–1571. doi:10.1111/jth.13369
Kronbichler A, Kerschbaum J, Gründlinger G, Leierer J, Mayer G, Rudnicki M (2016) Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis. Nephrol Dial Transplant 31(6):930–936. doi:10.1093/ndt/gfv336
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Rights and permissions
About this article
Cite this article
Kronbichler, A., Shin, J.I. Letter to the Editor: “Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis”. Clin Rheumatol 35, 2867–2868 (2016). https://doi.org/10.1007/s10067-016-3418-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3418-3